Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Dexketoprofen trometamol: An NSAID with improved safety and efficacy

Jan. 8, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

ImmuLogic files U.S. IND application for MS therapeutic

Jan. 7, 1997

First launch for Sumitomo antidepressant

Jan. 7, 1997

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Jan. 7, 1997

Cephalon files first NDA submission

Jan. 3, 1997

Cambridge NeuroScience/Gladstone Institute AD collaboration

Jan. 3, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Nippon Zoki claims aFGF fragments for CNS indications

Jan. 3, 1997

Debate centers on the safety of coated aspirin

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...